Subject: UVND Posts Terrific Financial Results TRTC Has Another Strong Retailer in Los Angeles Area

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
UVND Posts Terrific Financial Results TRTC Has Another Strong Retailer in Los Angeles Area
Hot Stock to WatchHot Stock to Watch

Company: U-Vend (OTCQB: UVND)

End of Day:

Price: 0.1665

Change (%): + 0.00 (0.00)

Volume: 0
UVND Chart

U-Vend, Inc. Announces First Quarter 2015 Financial Results

Company Posts Over 350% Increase in Revenue With 17% Decrease in Net Loss

SANTA MONICA, CA-(Marketwired - May 21, 2015) - U-Vend, Inc. (OTCQB: UVND) (the “Company”), a consumer products and technology company that develops, distributes and markets next-generation self-serve electronic kiosks in a variety of retail environments across North America, announced financial results for the first quarter ended March 31, 2015.

“We realized a significant increase in our quarter-over-quarter and 2015 comparable quarter revenue, which is a direct result of our efforts to expand our network of electronic kiosks. Our presence in the Southern California region has significantly increased and we will continue to seek growth opportunities in and outside our existing regions,” stated Raymond Meyers, CEO of U-Vend, Inc.

Continue Reading

Top PerformerYesterday's Top Performer

PositiveID Corporation (OTCQB: PSID)

End of Day:

Price: 0.0165

Change (%): + 0.0006 (3.77)

Volume: 2,211,191
PSID Chart

PositiveID Corporation to Present at the SeeThruEquity Microcap Investor Conference on May 28, 2015

DELRAY BEACH, Fla., May 20, 2015 (GLOBE NEWSWIRE) - PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced today that its Chairman and CEO, William J. Caragol, will present at the 4th Annual SeeThruEquity Microcap Investor Conference on Thursday, May 28, 2015 in New York City at Convene Grand Central.

SeeThruEquity is an equity research and corporate access firm focused on companies with less than 1 billion dollars in market capitalization. SeeThruEquity has initiated coverage on numerous NYSE, NASDAQ, TSX, and OTC companies in a variety of industries including technology, health care, consumer, energy and special situations.

Continue Reading

SmallCapVoice Clients' News

Terra Tech Corp (OTCQB: TRTC)

IVXX Premium Quality Cannabis Extracts Adds New Los Angeles Based Retail Partner

Oakland, May 21, 2015 (GLOBE NEWSWIRE) - Terra Tech Corp (TRTC), is pleased to give an update on the continued development of IVXX branded cannabis products. The Company is proud to announce that their brand of exceptional quality cannabis products is now available in Sylmar, California at One Stop Healers. One Stop Healers is a LA based Pre-ICO medical cannabis dispensary focused on providing patients with a broad array of cannabis products at affordable prices.

“Word is spreading throughout the Southern California market about IVXX and the reception has been strong,” explains Derek Peterson, CEO of Terra Tech. “It’s encouraging to see the excitement over the brands look as well as the quality of product.”

Continue Reading

Other Small Cap News

Company: VeriTeQ Corporation (Pink Sheets: VTEQ)

VeriTeQ Awarded New U.S. Patent for Wireless Molecular Sensor System and Process

Patent to be Used in Development of Bio-Sensing Microchip Applications

DELRAY BEACH, Fla., May 21, 2015 (GLOBE NEWSWIRE) -- VeriTeQ Corporation ("VeriTeQ" or the "Company") (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has been awarded a U.S. Patent for Wireless Molecular Sensor System and Process. The Company intends to utilize the patent in the development of future bio-sensing microchip applications, initially focused on its radiation dose measurement technologies used during cancer treatment.

This newest patent covers methods and systems for measuring and wirelessly communicating particular molecular levels using an implantable sensor device operable without the use of batteries. These implantable biosensor systems use radio frequency technology to wirelessly transmit information between a transponder passively powered on a chip and a remote transponder. Information transmitted via this wireless communication system quantifies a physiological metric with respect to the levels of specific molecules measured by the biosensor.

Continue Reading

Company: Nexus Enterprise Solutions, Inc. (OTCQB: NXES)

Nexus Enterprise Solutions, Inc. Reports First Quarter 2015 Results with Revenue up More Than 100% and a Return to Profitability

Company more than Doubles Revenue in Q1 2015 vs. Q1 2014 Fueled By Demand for Proprietary Prospecting Services Among Major Insurance Carriers

LIGHTHOUSE POINT, Fla.--(BUSINESS WIRE)--Nexus Enterprise Solutions, Inc. (OTCQB: NXES) (the “Company”), a digital prospecting services company serving the insurance industry, announced financial results for the quarter ending March 31, 2015.

"Our growing success is rooted in Nexus' ability to redefine the current prospect, lead generation and acquisition industry by providing insurers, and independent insurance agents, with an information exchange service which allows sellers and buyers of insurance leads to transact deals more efficiently in comparison to today's most commonly used lead generation systems," stated Bayardelle. "This has allowed us to greatly diversify our buyer-base and allow the carriers and agencies to hit their customer acquisition cost goals."

Continue Reading

Market News

By Peter Schacknow: CNBC

Early movers: BBY, OCR, HPQ, PFE, NKE, BABA & more

Best Buy - The electronics retailer reported adjusted quarterly profit of 37 cents per share, 8 cents above estimates, with revenue beating forecasts, as well. Comparable-store sales were up 0.6 percent, compared to consensus estimates of a 0.1 percent increase.

Omnicare - CVS Health is buying the pharmacy benefits manager for $10.4 billion in cash, or $98 per share. The value of the deal is $12.7 billion when assumed debt is included.

Hewlett-Packard - HP is selling 51 percent of its China-based data networking operation to China's Tsinghua Holdings.

Continue Reading

By Amanda Diaz:

Schiff: Fed's 'heroin' is about to wear off

While traders obsess over the timing of the Fed's next rate hike, Peter Schiff has a simple message for Wall Street: don't.

On CNBC's "Trading Nation," the outspoken investor said the central bank is "bluffing" and instead of waiting for a rate increase, traders should have their sights set on another round of quantitative easing.

"We are addicted to zero percent rates," he said. Schiff says that raising rates would "pop" the stock and real estate bubble that the Federal Reserve has created through its low-rate policies. And that would send the U.S. economy into a catastrophic recession. By his reasoning, the Fed will do anything to prevent stocks from falling. In fact, he sees more stimulus ahead.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks